Abstract

  Psoriasis is a long-lasting autoimmune disease characterized by patches of abnormal skin. Typical psoriatic scales are in thick, red patches. Sometimes, these patches will crack and bleed. Psoriasis is the result of a sped-up skin production process. Some of the drugs used in the treatment of psoriasis are Acitretin, Etretinate, Bergapten, Methoxsalen, Tazarotene, Calcipotriol, Anthralin etc. A brief review of the analytical methods developed for the determination of drugs used for the treatment of Psoriasis was discussed in the present study.

Keywords: Acitretin; Etretinate; Bergapten

References

1. Parisi R., et al. “Global epidemiology of psoriasis: a systematic review of incidence and prevalence". Journal of Investigative Dermatology 133.2 (2013): 377-385. 
2. Orfanos CE., et al. “Current use and future potential role of retinoids in dermatology”. Drugs 53.3 (1997): 358-388. 
3. Porwal PK., et al. “Assessment by HPLC of the degradation behavior of Acitretin under hydrolytic, oxidative, photolytic and thermal stress conditions”. Acta Pharmaceutica Sinica B 4.6 (2014): 438-446.
4. Porwal PK., et al. “Stability-indicating RP-HPLC method validation for Acitretin and its related substances in capsules”. Journal of Pharmaceutical Research 9.3 (2010): 122-125.
5. Devika Subramaniyan G., et al. “Determination of Acitretin in pharmaceutical formulations by HPLC method”. International Journal of Pharmaceutics and Drug Analysis 4.3 (2016): 147-152.
6. Srikanth Inturi., et al. “India Estimation of Acitretine in softule dosage form by HPTLC method”. Journal of Pharmacy Research 5.5 (2012): 2926-2929.
7. Kumar A., et al. “Stability-indicating validation of Acitretin and isoacitretin in human plasma by LC-ESI-MS/MS bioanalytical method and its application to pharmacokinetic analysis”. Biomedical Chromatography 25.6 (2011): 680-688. 
8. Saurat JH., et al. “Retinoids and psoriasis: Novel issues in retinoid pharmacology and implications for psoriasis treatment”. Journal of the American Academy of Dermatology 41.3 (1999): S2-6. 
9. Wyss R., et al. “Quantitative analysis of retinoids in biological fluids by high-performance liquid chromatography using column switching. II. Simultaneous determination of Etretinate, Acitretin and 13-cis-Acitretin in plasma”. Journal of Chromatography 431.2 (1988): 297-307.
10. Honigsmann., et al. "5-Methoxypsoralen (Bergapten) in photo chemotherapy of psoriasis". British Journal of Dermatology 101 (1979) 369-378. 
11. Gao Y., et al. “Pharmacokinetic studies of Bergapten in dog plasma by using a LC-MS/MS method studies”. Drug Research 63.7 (2013): 338-341.
12. Von Weymarn LB., et al. “Effects of 8-methoxypsoralen on cytochrome P450 2A13”. Carcinogenesis 26.3 (2005): 621-629.
13. Monbaliu JG., et al. “Analysis of Methoxsalen in plasma by reversed-phase high-performance liquid chromatography”. Journal of Pharmaceutical Sciences 70.8 (1981): 965-966. 
14. Kucová D., et al.“ High-performance liquid chromatographic determination of Methoxsalen in plasma after liquid-solid extraction”. Journal of chromatography 614.2 (1993): 340-344.
15. Lehr GJ., et al. “LC determination of impurities in Methoxsalen drug substance: isolation and identification of isopimpinellin as a major impurity by atmospheric pressure chemical ionization LC/MS and NMR”. Journal of Pharmaceutical and Biomedical Research 33.4 (2003): 627-637.
16. Attar M., et al. “Cytochrome P450 2C8 and flavin-containing monooxygenases are involved in the metabolism of Tazarotenic acid in humans”. 31.4 (2003): 476-481.
17. Mrunali R., et al. “HPTLC method for estimation of Tazarotene in topical gel formulations and in vitro study”. Analytical methods 3 (2010).
18. Eman S., et al “A novel simple method for resolving overlapped spectral data with a wide range of applicability, and its application as a stability indicating method for determination of Tazarotene”. Pharmaceutica Analytica Acta 3.10 (2012): 2153-2435.
19. Chinmoy Roy., et al “Stability indicating RP-HPLC method development and validation for determination of process related impurities and degradation products of Tazarotene in Tazarotene topical formulation”. Indo American Journal of Pharmaceutical Research 3.1 (2012): 1400-1413.
20. Kim DH., et al. "Successful treatment of alopecia areata with topical Calcipotriol". Annals of Dermatology 24.3 (2012): 341-344. 
21. Madhulika Pradhan., et al “Development and Validation of a Robust RP-HPLC Method for Analysis of Calcipotriol in Pharmaceutical Dosage Form”. Research Journal of Pharmacy and Technology 12.2 (2019): 579-583.
22. Ashton RE, et al. “Anthralin: historical and current perspectives”. Journal of the American Academy of Dermatology 9.2 (1983): 173-192. 
23. Sunil prakash C., et al. “Development of RP-HPLC method for estimation of Dithranol in hydrogel based lipid nanoparticle formulation”. Current Trends in Technology and Sciences 1.2 (2012): 104-107.
24. Suja George., et al “A Simple RP-HPLC method for the determination of the anti-psoriatic drug Dithranol and its application in an in vitro cell uptake study”. Current Pharmaceutical Analysis 8.1 (2012): 75-82.

Citation

Citation: Sistla Mounica Pratyusha and Choppala Asha Deepti. “Analytical Methods for the Determination of Anti-Psoriatic Drugs - A Review". Acta Scientific Pharmaceutical Sciences 4.2 (2020): 94-97.